Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis-Reference-Cited by-同舟云学术

Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis

Published:2013-04-17 Issue:5 Volume:28 Page:1229-1242
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Logan John G,Sophocleous Antonia,Marino Silvia,Muir Morwenna,Brunton Valerie G,Idris Aymen I

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.1847/fullpdf

Reference52 articles.

1. Metastasis to bone: causes, consequences and therapeutic opportunities;Mundy;Nat Rev Cancer.,2002

2. Pathogenesis of bone metastasis: a review;Raubenheimer;J Oral Pathol Med.,2006

3. http://www.cancer.org/research/cancerfactsfigures/cancer-facts-figures-2007

4. Molecular mechanisms of osteolytic bone metastases;Guise;Cancer.,2000

5. Skeletal complications of breast cancer therapies;Hirbe;Clin Cancer Res.,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological activity and mechanism of pyrazines;European Journal of Medicinal Chemistry;2023-10

2. AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review;Cancers;2021-05-11

3. Role of NFκB in Bone Remodeling in Health and Cancer;Encyclopedia of Bone Biology;2020

4. Engineering Models in Cancer;Encyclopedia of Bone Biology;2020

5. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice;EBioMedicine;2019-06